ArticleCancer medicine2025

A Real-World Pharmacovigilance Study of Fruquintinib Based on the FDA Adverse Event Reporting System (FAERS) Database.

Yajing Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.